Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice

Transfusion

Volumn 44, Issue 12, 2004, Pages 1700-1705

  Yakovleva, Oksana ^b   Janiak, Anna ^b   McKenzie, Carroll ^b   McShane, Lisa ^b   Brown, Paul ^b   Cervenakova, Larisa ^a  

^a HOLLAND LABORATORY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANAZOLENE SODIUM; ANTIBODY; PLASMA PROTEIN; PRION PROTEIN; PROTEINASE K;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD COMPONENT; BLOOD SAMPLING; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; INCUBATION TIME; INFECTION; INOCULATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; WESTERN BLOTTING;

ANIMALS; BLOOD PROTEINS; CREUTZFELDT-JAKOB SYNDROME; ENDOPEPTIDASE K; MICE; PRPC PROTEINS; TIME FACTORS;

EID: 10444235674     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.04198.x     Document Type: Article

References (36)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
2. Department of Health. Monthly Creutzfeldt-Jakob disease statistics (Internet). London: The Department; 2004. Available from: http://www.dh.gov.uk
3. The European and Allied Countries Collaborative Study Group of CJD (Euro CJD). Available from: http:// www.eurocjd.ed.uc.uk/vCJD.htm.
4. Andrews NJ, Farrington CP, Ward HJ, et al. Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 2003;361:751-2.
5. Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-9.
6. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
7. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.
8. Brown P, Rohwer RG, Dunstan BC, et al. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998;38:810-6.
9. Brown P, Cervenakova L, McShane LM, Barber P, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999;39: 1169-78.
10. Cervenakova L, Yakovleva O, McKenzie C, et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003;43:1687-94.
11. Rohwer RG. Titer, distribution, and transmissibility of blood-borne TSE infectivity. Presented at the Cambridge Healthtech Institute 6th Annual Meeting, "Blood Product Safety: TSE, Perception versus Reality"; 2000 Feb 13-15; MacLean, VA.
12. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000;356:999-1000.
13. Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002;83:2897-905.
14. Brown P, Cervenakova L, Diringer H. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 2001;137:5-15.
15. Turk E, Teplow DB, Hood LE, Prusiner SB. Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem 1988;176:21-30.
16. Cervenakova L, Brown P, Soukharev S, et al. Failure of immuno-competitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease. Electrophoresis 2003;24:853-9.
17. Peto S. A dose-response equation for the invasion of microorganisms. Biometrics 1953;9:320-35.
18. Ridout MS, Fenlon JS, Hughes PR. A generalized one-hit model for bioassays of insect viruses. Biometrics 1993;49:1136-41.
19. MacGregor I, Hope I, Barnard G, et al. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sang 1999;77:88-96.
20. Holada K, Vostal JG. Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells. Br J Haematol 2000;110:472-80.
21. Vostal JG, Holada K, Simak J. Expression of cellular prion protein on blood cells: potential functions in cell physiology and pathophysiology of transmissible spongiform encephalopathy diseases. Transfus Med Rev 2001;15:268-81.
22. MacGregor I, Drummond O, Turner M, Barclay R, Prowse C. Distribution of normal prion protein in blood. Transfus Sci 2000;22:51.
23. Volkel D, Zimmermann K, Zerr I, et al. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 2001;41:441-8.
24. Simak J, Holada K, D'Agnillo F, Janota J, Vostal JG. Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 2002;42:334-42.
25. MacGregor I, Drummond O. Immunoassay of human plasma cellular prion protein. Transfusion 2001;41:1453-4.
26. Schreuder BE, van Keulen LJ, Vromans ME, Langeveld JP, Smits MA. Tonsilar biopsy and PrPSc detection in the preclinical diagnosis of scrapie. Vet Rec 1998;142:564-8.
27. O'Rourke KI, Baszler TV, Besser TE, et al. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol 2000;38:3254-9.
28. Hill AF, Zeidler M, Ironside JW, Collinge J. Diagnosis of new variant Creutzfedt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.
29. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998;352:703-4.
30. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfedt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9.
31. Hilton DA, Sutak I, Smith ME, et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004;57:300-2.
32. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;349:1812-20.
33. Taylor DM, Fernie K, Reichel HE, Somerville RA. Infectivity in the blood of mice with a BSE-derived agent (letter). J Hosp Infect 2000;46:78-9.
34. Paramithiotis E, Pinard M, Lawton T, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat Med 2003;9:893-9.
35. Wilson S. Use of the Seprion ligand system in ante-mortem testing for TSEs. CHI Annual Conference on TSE; 2004 Feb 23-24; Washington.
36. Sc conformers induced by a synthetic peptide and several prion strains. J Virol 2004;78:2088-99.